首页> 外文期刊>British journal of ophthalmology >Short wavelength-automated perimetry compared with standard achromatic perimetry in autosomal dominant optic atrophy.
【24h】

Short wavelength-automated perimetry compared with standard achromatic perimetry in autosomal dominant optic atrophy.

机译:短波长自动视野检查与标准消色差视野检查相比常染色体显性视神经萎缩。

获取原文
获取原文并翻译 | 示例
       

摘要

BACKGROUND: Autosomal dominant optic atrophy (ADOA, Kjer-type) is a heterogeneous, non-inflammatory degeneration of retinal ganglion cells. The diagnosis of ADOA can be challenging owing to its insidious onset and large variability in phenotypic expression, both within and between individual pedigrees. The earliest literature reports relatively mild centrocaecal scatomas to white targets in ADOA, but extensive and dense peripheral field loss to coloured targets, especially blue, with Bjerrum perimetry. The phrase "inverted peripheral visual fields to coloured targets" has been used to describe this phenomenon. METHODS: Humphrey standard achromatic perimetry (SAP) and short wavelength-automated perimetry (SWAP) were carried out on five patients with ADOA. RESULTS: Regardless of wide variations in patient age, visual acuity, disc appearance and colour vision, the SWAP mean deviation (MD) was between 10 and 20 times more depressed than the SAP MD. The actual differences ranged from 9.38 to 13.78 dB. CONCLUSIONS: These data are consistent with the original reports suggesting that, early in this disease process, the blue-target deficits are typically peripheral and that this difference between SAP and SWAP perimetry may be a robust indicator of ADOA in both early and late stages of this disease.
机译:背景:常染色体显性视神经萎缩(ADOA,Kjer型)是视网膜神经节细胞的异质性,非炎性变性。 ADOA的起病隐匿,并且在个体谱系之内和之间,其表型表达差异很大,因此诊断可能具有挑战性。最早的文献报道在ADOA中相对于白色靶标而言相对轻度的中央巩膜炎,但通过Bjerrum视野测定法,有色靶标尤其是蓝色靶标广泛而密集的周围视野丧失。短语“将外围视野反转为有色目标”已用于描述此现象。方法:对5例ADOA患者进行了汉弗莱标准消色差视野测定(SAP)和短波自动视野测定(SWAP)。结果:无论患者年龄,视敏度,椎间盘外观和色觉变化如何,SWAP平均偏差(MD)均比SAP MD降低10至20倍。实际差异范围为9.38至13.78 dB。结论:这些数据与原始报告一致,表明在该疾病过程的早期,蓝色靶点缺陷通常是外围的,SAP和SWAP视野检查法之间的差异可能是ADOA早期和晚期的有力指标。这种病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号